All
Acetylcholinesterase inhibitors associated with lower risk of AMD in Alzheimer disease patients
January 10th 2024The data indicated that patients with Alzheimer’s disease who were treated with acetylcholinesterase inhibitors had a slightly lower hazard of developing AMD compared with untreated patients.
RetinalGeniX Technologies contracts with MEDsan to provide diagnostic testing services
January 2nd 2024According to a news release, the services will be provided for RetinalGeniX Technologies’ Institutional Review Board to conduct a study to personalize medical evaluations for patients receiving treatment for wet macular degeneration.